These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32044720)

  • 1. ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with β-catenin.
    Wang W; He S; Zhang R; Peng J; Guo D; Zhang J; Xiang B; Li L
    Biomed Pharmacother; 2020 May; 125():109940. PubMed ID: 32044720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
    J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
    Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
    Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
    Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
    Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
    Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
    Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
    Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
    Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OV6
    Wang C; Yan FH; Zhang JJ; Huang H; Cui QS; Dong W; Zhang WW; Zhao Y; Chen HZ; Zhao TJ
    Cancer Lett; 2017 Apr; 391():100-113. PubMed ID: 28131903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
    Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
    Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma.
    Zhai Y; Shan C; Zhang H; Kong P; Zhang L; Wang Y; Hu X; Cheng X
    Mol Cell Biochem; 2022 Dec; 477(12):2689-2702. PubMed ID: 35606602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.
    Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y
    Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Yang L; Ren Y; Yu X; Qian F; Bian BS; Xiao HL; Wang WG; Xu SL; Yang J; Cui W; Liu Q; Wang Z; Guo W; Xiong G; Yang K; Qian C; Zhang X; Zhang P; Cui YH; Bian XW
    Mod Pathol; 2014 May; 27(5):775-83. PubMed ID: 24201124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET/Fyn/β-catenin signaling pathway.
    Yuan H; Zhou W; Yang Y; Xue L; Liu L; Song Y
    Exp Cell Res; 2018 Jun; 367(1):47-55. PubMed ID: 29555370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
    Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
    Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
    Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
    Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.